Boston Scientific announces positive results from its Champion-Af study
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The study evaluated the performance of the Watchman Flx™ left atrial appendage occluder as a first-line therapy for reducing stroke risk. Research data show that the Watchman Flx™ device met all predefined primary safety endpoints and primary efficacy endpoints. At the same time, all secondary safety and efficacy endpoints were also successfully achieved. These results indicate that, as a first-line therapy, the device demonstrates excellent safety and efficacy, offering an important new option for stroke prevention.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Probability of Bitcoin Rising to $100,000 This Year on Polymarket Drops to 37%
Cointime•2026/05/24 13:50
Bond strategist warns that even if the Iran war ends, yields will remain high
华尔街见闻•2026/05/24 13:49
A certain whale longed 25x the value of $12.6 million in gold
BlockBeats•2026/05/24 13:36
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$76,745.77
+2.11%
Ethereum
ETH
$2,107.43
+3.18%
Tether USDt
USDT
$0.9988
-0.01%
BNB
BNB
$657.86
+2.45%
XRP
XRP
$1.36
+1.93%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$86.17
+3.79%
TRON
TRX
$0.3649
+1.67%
Dogecoin
DOGE
$0.1029
+2.49%
Hyperliquid
HYPE
$63.48
+15.33%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now